Skip to main content
新赣江 logo

新赣江 — Investor Relations & Filings

Ticker · 920367 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2025-08-06 Governance Information
Country CN China
Listing Beijing Stock Exchange 920367

About 新赣江

http://www.xgjyy.com/

Jiangxi Xinganjiang Pharmaceutical Co., Ltd. specializes in the research, development, production, and distribution of a diverse range of pharmaceutical products. The company's portfolio encompasses chemical active pharmaceutical ingredients (APIs), chemical drug preparations, and traditional Chinese medicine (TCM) formulations. Its core product offerings target therapeutic areas such as cardiovascular and cerebrovascular health, digestive system disorders, and nutritional supplementation. Key products include Ginkgo Biloba extract, Vitamin C, and various gastrointestinal medications. By maintaining an integrated value chain that spans from raw material synthesis to finished dosage forms, the company ensures quality control and supply chain efficiency. It focuses on delivering high-quality healthcare solutions through continuous innovation in pharmaceutical manufacturing and formulation technology.

Recent filings

Filing Released Lang Actions
信息披露事务管理制度
Governance Information Classification · 95% confidence The document is a detailed disclosure of the company's internal information disclosure management system, including principles, procedures, responsibilities, and regulatory compliance related to information disclosure. It references regulatory bodies such as the China Securities Regulatory Commission and Beijing Stock Exchange, and discusses the preparation and disclosure of periodic reports (annual, interim, quarterly), temporary reports, and other disclosures. The document is not a financial report itself but a governance and compliance document outlining the company's information disclosure policies and procedures. It does not contain financial statements or earnings data, nor is it an announcement of a specific event or report publication. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-06 Chinese
网络投票实施细则
Governance Information Classification · 95% confidence The document is a detailed announcement of the implementation rules for online voting at the company's shareholder meetings. It includes voting procedures, preparation, and rules for shareholders to exercise voting rights via an online system. It references the company's board meeting resolutions and states that the proposal will be submitted to the shareholders' meeting for approval. There are no financial statements, earnings data, or audit information. The document is not a report but a regulatory announcement about internal governance procedures related to shareholder voting. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-06 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled '江西新赣江药业股份有限公司董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors of Jiangxi Xinganjiang Pharmaceutical Co., Ltd.' It details the internal rules, procedures, and governance structure of the company's board meetings, including the responsibilities, meeting convocations, voting procedures, and record-keeping. There is no financial data, earnings information, or shareholder voting results presented. The document is a detailed governance framework for the board of directors, consistent with governance information filings. It is not an announcement of a report but the actual governance rules document. Therefore, the appropriate classification is Governance Information (CGR).
2025-08-06 Chinese
第三届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 11th meeting of the 3rd Board of Directors of Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to related disclosures on the stock exchange platform. The content focuses on board decisions, internal governance changes, and procedural matters. There is no financial data, earnings information, or audit content. The document is not a full report but a formal announcement of board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is about 5476 characters, which is sufficient for a detailed board meeting announcement. Therefore, the classification is MANG with high confidence.
2025-08-06 Chinese
承诺管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system related to commitment management by the company and its board, including procedures, responsibilities, and legal compliance. It is not a financial report, earnings release, or regulatory filing announcement. It does not announce voting results or changes in management but rather outlines governance policies and internal rules. The document is substantive and not a brief announcement or certification. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-06 Chinese
重大信息内部报告制度
Governance Information Classification · 95% confidence The document is titled as an internal reporting system for major information of Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It details the company's internal procedures, responsibilities, and obligations for reporting significant information within the company. The content includes governance and compliance rules related to information disclosure, internal reporting obligations, and management responsibilities. There is no financial data, earnings information, or shareholder voting results. It is not an announcement of a report but a detailed internal governance document. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-06 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.